Your cart is empty.

Browse Categories


Search


Stay In Touch


Login



Hazard Analysis and Critical Control Points

Price: From $398.00 to $1,595.00

Product Options

In the pharmaceutical industry, especially in early stage development, establishing a HACCP program can make the difference between failure and success. An effective program can not only save money, but also reduce "time to market" which is critical for a company's profitability. Incorporating the QC/QA functions into the HACCP early on can smooth the way to compliance. This session will focus on a new way of looking at HACCP.
  • Establishing cost benefit of early compliance
  • Assessing documentation for compliance
  • Establishing the role of validation
  • Discussing QA as a major player on the HACCP team
You will benefit from purchasing this web seminar if you are a Vice President, Director or a Supervisor of the following departements at a pharmaceutical, biotechnology or medical device company.
  • Quality Assurance
  • Quality Control
  • Regulatory Affairs
  • Risk Management
  • Validation
  • Pre-Approval
  • Product Safety
  • Compliance
  • Audit
  • Legal
  • Manufacturing
  • Development
About Our Presenter
John J. Vajda, BS, Managing Consultant, BFC Consultants
Mr. Vajda is an experience senior executive with backgrounds in pharmaceuticals, IVD devices, diagnostics and general instrumentation including electronic and optical assembly. He is a frequent speaker, nationally and internationally, on validation, process and design issues. His expertise includes process development, manufacturing, materials, engineering, facilities design and management, QC/QA, IT, marketing and regulatory affairs. Special skills include animal husbandry and facility designs, process and utilities validation and business development.
Prior to BFC, Mr. Vajda was at Centaur Pharmaceuticals from January 1997 as Director of Operations and became Vice President in February 1998 and Senior Vice President, Operations in charge of Process Development, Manufacturing, Engineering, Facilities, QC/QA, EH&S and IS in February 1999. Prior to joining Centaur, Mr. Vajda was General Manager of Biostride, Inc., and in-vitro diagnostic products company.

Product Reviews

(0 Ratings, 0 Reviews)